PT - JOURNAL ARTICLE AU - Keisuke Watanabe AU - Shigeki Hirano AU - Kazuho Kojima AU - Kengo Nagashima AU - Hiroki Mukai AU - Takatoshi Sato AU - Minoru Takemoto AU - Koji Matsumoto AU - Takashi Iimori AU - Sagiri Isose AU - Shigeki Omori AU - Kazumoto Shibuya AU - Yukari Sekiguchi AU - Minako Beppu AU - Hiroshi Amino AU - Tomoki Suichi AU - Koutaro Yokote AU - Takashi Uno AU - Satoshi Kuwabara AU - Sonoko Misawa TI - Altered cerebral blood flow in the anterior cingulate cortex is associated with neuropathic pain AID - 10.1136/jnnp-2017-316601 DP - 2018 Oct 01 TA - Journal of Neurology, Neurosurgery & Psychiatry PG - 1082--1087 VI - 89 IP - 10 4099 - http://jnnp.bmj.com/content/89/10/1082.short 4100 - http://jnnp.bmj.com/content/89/10/1082.full SO - J Neurol Neurosurg Psychiatry2018 Oct 01; 89 AB - Objective To assess the cerebral blood flow (CBF) in patients with diabetic neuropathic pain, and its changes after duloxetine therapy.Methods Using iodine-123-N-isopropyl-p-iodoamphetamine single-photon emission computed tomography (IMP-SPECT), we performed a cross-sectional study of 44 patients with diabetes, and compared CBF in those with (n = 24) and without neuropathic pain (n = 20). In patients with neuropathic pain, we also longitudinally assessed changes in CBF 3 months after treatment with duloxetine.Results IMP-SPECT with voxel-based analyses showed a significant increase in cerebral blood flow in the right anterior cingulate cortex and a decrease in the left ventral striatum in patients with neuropathic pain, compared with those without pain. After duloxetine treatment, volume of interest analyses revealed a decrease in cerebral blood flow in the anterior cingulate cortex in patients with significant pain relief but not in non-responders. Furthermore, voxel-based whole brain correlation analyses demonstrated that greater baseline CBF in the anterior cingulate cortex was associated with better pain relief on the numerical rating scale.Conclusions Our results suggest that the development of neuropathic pain is associated with increased activity in the anterior cingulate cortex, and greater baseline activation of this region may predict treatment responsiveness to pharmacological intervention.Trial registration number UMIN000017130;Results.